HeartSciences Inc.
HSCS
$3.03
$0.217.45%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.70K | 6.30K | 4.40K | 0.00 | 14.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.70K | 6.30K | 4.40K | 0.00 | 14.70K |
| Cost of Revenue | 3.70K | 2.70K | 1.90K | 0.00 | 4.60K |
| Gross Profit | 5.00K | 3.60K | 2.50K | 0.00 | 10.10K |
| SG&A Expenses | 4.56M | 4.00M | 3.97M | 3.81M | 3.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.25M | 8.16M | 8.36M | 8.31M | 7.48M |
| Operating Income | -8.24M | -8.15M | -8.35M | -8.31M | -7.47M |
| Income Before Tax | -9.04M | -8.77M | -8.77M | -8.52M | -7.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.04 | -8.77 | -8.77 | -8.52 | -7.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.04M | -8.77M | -8.77M | -8.52M | -7.62M |
| EBIT | -8.24M | -8.15M | -8.35M | -8.31M | -7.47M |
| EBITDA | -8.21M | -8.12M | -8.32M | -8.27M | -7.43M |
| EPS Basic | -6.95 | -8.37 | -9.44 | -10.31 | -10.74 |
| Normalized Basic EPS | -4.34 | -5.23 | -5.90 | -6.44 | -6.72 |
| EPS Diluted | -6.95 | -8.37 | -9.44 | -10.31 | -10.74 |
| Normalized Diluted EPS | -4.34 | -5.23 | -5.90 | -6.44 | -6.72 |
| Average Basic Shares Outstanding | 6.14M | 4.28M | 3.75M | 3.33M | 2.89M |
| Average Diluted Shares Outstanding | 6.14M | 4.28M | 3.75M | 3.33M | 2.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |